Vitalhub Corp. (TSE:VHI) Given Consensus Recommendation of "Buy" by Brokerages

Key Points

• Consensus "Buy": Seven brokerages cover Vitalhub (six Buy, one Strong Buy) with an average 12‑month price target of C$13.86, though several firms recently trimmed targets while maintaining outperform ratings.
• Significant insider buying: Two directors bought shares recently (Anthony P. Shen 7,000 at C$7.11; Francis N. Shen 50,000 at C$6.99), insiders purchased 496,600 shares (~C$3.48M) in the last 90 days and now own 18.57% of the company.
• Recent market and financials: VHI opened at C$6.97 (50‑day MA C$7.73, 200‑day MA C$9.02), market cap ~C$441M, P/E 69.7, 52‑week range C$6.67–C$14.64, and reported Q earnings of C$0.06 on C$31.39M revenue with analysts forecasting ~0.23 EPS for the year.

Shares of Vitalhub Corp. (TSE:VHI - Get Free Report) have been given a consensus rating of "Buy" by the seven brokerages that are covering the firm, MarketBeat.com reports. Six research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is C$13.86.

VHI has been the subject of several recent analyst reports. ATB Cormark Capital Markets cut their target price on Vitalhub from C$16.50 to C$15.00 and set an "outperform" rating for the company in a research note on Tuesday, March 10th. Royal Bank Of Canada dropped their price objective on Vitalhub from C$13.00 to C$12.00 and set an "outperform" rating for the company in a research note on Monday, January 26th. Scotiabank dropped their price objective on Vitalhub from C$15.00 to C$12.00 and set an "outperform" rating for the company in a research note on Wednesday, February 4th. Finally, Raymond James Financial dropped their price objective on Vitalhub from C$15.00 to C$11.00 and set an "outperform" rating for the company in a research note on Tuesday, March 24th.

Insiders Place Their Bets

In other news, Director Anthony Pius Shen acquired 7,000 shares of the company's stock in a transaction dated Monday, March 30th. The stock was acquired at an average cost of C$7.11 per share, with a total value of C$49,770.00. Following the completion of the purchase, the director owned 12,470 shares of the company's stock, valued at C$88,661.70. This represents a 127.97% increase in their position. Also, Director Francis Nelson Shen acquired 50,000 shares of the company's stock in a transaction dated Thursday, March 26th. The stock was purchased at an average cost of C$6.99 per share, with a total value of C$349,500.00. Following the completion of the purchase, the director directly owned 50,000 shares of the company's stock, valued at approximately C$349,500. This represents a ∞ increase in their position. Insiders bought 496,600 shares of company stock valued at $3,476,470 over the last ninety days. Insiders own 18.57% of the company's stock.

Vitalhub Stock Down 2.2%

VHI stock opened at C$6.97 on Friday. The business has a fifty day moving average of C$7.73 and a two-hundred day moving average of C$9.02. The stock has a market cap of C$440.73 million, a price-to-earnings ratio of 69.70, a price-to-earnings-growth ratio of 1.18 and a beta of 0.90. Vitalhub has a 52-week low of C$6.67 and a 52-week high of C$14.64.

Vitalhub (TSE:VHI - Get Free Report) last posted its earnings results on Wednesday, March 18th. The company reported C$0.06 earnings per share (EPS) for the quarter. The company had revenue of C$31.39 million during the quarter. Vitalhub had a return on equity of 2.75% and a net margin of 5.61%. As a group, sell-side analysts anticipate that Vitalhub will post 0.2296467 EPS for the current year.

About Vitalhub

Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.